EXELIXIS INC (EXEL) Stock Analyst Ratings
USA - NASDAQ:EXEL - US30161Q1040 - Common Stock
40.81 USD
+0.01 (+0.02%)
42 USD
+1.19 (+2.92%)
ChartMill assigns a Buy % Consensus number of 78% to EXEL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 44.77. This target is 9.71% above the current price.
EXEL was analyzed by 26 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about EXEL.
In the previous month the buy percentage consensus was at a similar level.
EXEL was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-03 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-10-21 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-10-21 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-10-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-17 | Barclays | Initiate | Equal-Weight |
| 2025-09-17 | Goldman Sachs | Initiate | Buy |
| 2025-09-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-30 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-29 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-07-29 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-07-29 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-29 | Stifel | Maintains | Hold -> Hold |
| 2025-07-29 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-24 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2025-06-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-23 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-06-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-05 | B of A Securities | Maintains | Neutral -> Neutral |
EXELIXIS INC / EXEL FAQ
Can you provide the average price target for EXELIXIS INC stock?
26 analysts have analysed EXEL and the average price target is 44.77 USD. This implies a price increase of 9.71% is expected in the next year compared to the current price of 40.81.
What is the consensus rating for EXEL stock?
The consensus rating for EXELIXIS INC (EXEL) is 78.4615 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover EXELIXIS INC (EXEL) stock?
The number of analysts covering EXELIXIS INC (EXEL) is 26.